deltatrials
Active Not Recruiting OBSERVATIONAL NCT01745471

Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL) (EIFFEL)

Adipose Tissue Angiogenesis in Polycystic Ovary Syndrome (PCOS)

Sponsor: AdventHealth Translational Research Institute

Conditions Metabolic Diseases Overweight Polycystic Ovary Syndrome
Updated 20 times since 2017 Last updated: Aug 1, 2025 Started: Dec 6, 2012 Primary completion: Apr 4, 2024 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01745471, this observational or N/A phase trial focuses on Metabolic Diseases and Overweight and remains ongoing. Sponsored by AdventHealth Translational Research Institute, it has been updated 20 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Apr 2020 · 13 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jul 2023 · 14 months · monthly snapshot~Jul 2023 – ~Mar 2024 · 8 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting

  2. Apr 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  3. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  5. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting

▶ Show 15 earlier versions

  1. Jul 2023 — Mar 2024 [monthly]

    Active Not Recruiting

  2. May 2022 — Jul 2023 [monthly]

    Active Not Recruiting

  3. Mar 2022 — May 2022 [monthly]

    Active Not Recruiting

  4. Dec 2021 — Mar 2022 [monthly]

    Active Not Recruiting

  5. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  6. Apr 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  7. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting

  8. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  9. Apr 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  10. Mar 2019 — Apr 2020 [monthly]

    Active Not Recruiting

  11. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting

  12. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting

  13. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  14. Aug 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

  15. Jan 2017 — Aug 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AdventHealth Translational Research Institute
  • Boston University
  • Pennington Biomedical Research Center
  • Sanford-Burnham Medical Research Institute
  • Tufts University
Data source: AdventHealth Translational Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations